Toggle Main Menu Toggle Search

Open Access padlockePrints

Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

Lookup NU author(s): Dr Alex Blain

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2021 The Author(s). DDX3X is a ubiquitously expressed RNA helicase involved in multiple stages of RNA biogenesis. DDX3X is frequently mutated in Burkitt lymphoma, but the functional basis for this is unknown. Here, we show that loss-of-function DDX3X mutations are also enriched in MYC-translocated diffuse large B cell lymphoma and reveal functional cooperation between mutant DDX3X and MYC. DDX3X promotes the translation of mRNA encoding components of the core translational machinery, thereby driving global protein synthesis. Loss-of-function DDX3X mutations moderate MYC-driven global protein synthesis, thereby buffering MYC-induced proteotoxic stress during early lymphomagenesis. Established lymphoma cells restore full protein synthetic capacity by aberrant expression of DDX3Y, a Y chromosome homolog, the expression of which is normally restricted to the testis. These findings show that DDX3X loss of function can buffer MYC-driven proteotoxic stress and highlight the capacity of male B cell lymphomas to then compensate for this loss by ectopic DDX3Y expression.


Publication metadata

Author(s): Gong C, Krupka JA, Gao J, Grigoropoulos NF, Giotopoulos G, Asby R, Screen M, Usheva Z, Cucco F, Barrans S, Painter D, Zaini NBM, Haupl B, Bornelov S, Ruiz De Los Mozos I, Meng W, Zhou P, Blain AE, Forde S, Matthews J, Khim Tan MG, Burke GAA, Sze SK, Beer P, Burton C, Campbell P, Rand V, Turner SD, Ule J, Roman E, Tooze R, Oellerich T, Huntly BJ, Turner M, Du M-Q, Samarajiwa SA, Hodson DJ

Publication type: Article

Publication status: Published

Journal: Molecular Cell

Year: 2021

Volume: 81

Issue: 19

Pages: 4059-4075.e11

Print publication date: 07/10/2021

Online publication date: 25/08/2021

Acceptance date: 28/07/2021

Date deposited: 25/08/2023

ISSN (print): 1097-2765

ISSN (electronic): 1097-4164

Publisher: Cell Press

URL: https://doi.org/10.1016/j.molcel.2021.07.041

DOI: 10.1016/j.molcel.2021.07.041

PubMed id: 34437837


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
15022
203151/Z/16/Z
900186
Addenbrooke's Charitable Trust
C9685/A25163
Cancer Research UK
Blood Cancer UK
BRC-1215-20014
C49940/A25117
ET19/27
Evelyn Trust
KKL1144
KKLF1398
MRC
Kay Kendall Leukaemia Fund
MR/M008584/1
RCCFEL∖100072
Wellcome Trust

Share